Last update 08 May 2025

CD29 x LAMA4 x EGFR

Basic Info

Related Targets
CD29LAMA4EGFR

Related

1
Drugs associated with CD29 x LAMA4 x EGFR
AG-101
Target
CD29 x EGFR x LAMA4
Mechanism
CD29 inhibitors [+2]
Active Org.
Arrogene, Inc.Arrogene, Inc.
Originator Org.
Cedars-Sinai Health System
Active Indication
Breast Cancer [+2]
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with CD29 x LAMA4 x EGFR
Login to view more data
100 Translational Medicine associated with CD29 x LAMA4 x EGFR
Login to view more data
0 Patents (Medical) associated with CD29 x LAMA4 x EGFR
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free